Diary

This three-part webinar provides an in-depth focus on the recognition and prevention of technical issues that occur in ICC, and guidance on ways to ensure ICC quality in diagnostic cellular pathology. After the session, attendees will be able to: select high quality antibodies appropriate for the demonstration of common tissue biomarkers; evaluate the staining of new antibodies and methodologies and identify quality staining results; resolve issues associated with antibody titres, retrieval protocols and non-specific staining.

Times: 09:00 - 12:00

Inspiring the future of laboratories - lead the charge in scientific innovation and step into the UK hub for laboratory professionals. At the UK’s biggest laboratory event, you’ll connect with 4,700+ scientists, laboratory managers, R&D experts, and quality professionals – all eager to discover what’s new.

This three-part webinar provides a focus on the more advanced ICC/ISH applications currently being utilised in diagnostic cellular pathology. Delegates will acquire the knowledge on the use of routine diagnostic ICC and drug aligned companion diagnostic assays use. After the session, attendees will be able to: understand the appropriate antibodies for the identification of the pathological origins of a tumour and their diagnostic value; understand the rationale and pitfalls associated with the demonstration of biomarkers such as HER2, ER, PR, PD-L1, ALK, BRAF and MMR proteins; understand the requirements for successful EQA assessment of IHC staining of biomarkers such as HER2, ER, PR, PD-L1, ALK, BRAF and MMR proteins.

Times: 09:00 - 12:00

The British Association for Cytopathology's 2026 Annual Scientific Meeting will take place on Friday 13 November, in Newcastle upon Tyne.  It will include the organisation's AGM. More details to follow.

Senior leaders from some of the world’s foremost regulatory authorities, pharmaceutical companies, health technology organisations, academic institutions and patient groups will come together in London this November as the Medicines and Healthcare products Regulatory Agency (MHRA) and the Drug Information Association (DIA) host the inaugural DIA-MHRA Global Summit. Held on 16 and 17 November 2026 alongside a significant programme of activity throughout London Life Sciences Week, the Summit will provide a unique international forum for regulators, industry leaders, academics, investors, technology innovators and patient representatives to explore how healthcare systems can work together to support innovation while maintaining public trust and patient safety.

POCT Innovators' 13th face-to-face event is in development and speaker profiles will be released in the next few weeks. The booking page is now live at the link below. Places are free for the NHS and public sector and affordable for commercial attendees.

UK NEQAS for Microbiology & Parasitology will be hosting its annual Scientific Meeting on 27 November 2026 in Central London.

Please ‘save the date’ for our lively and well attended meeting (agenda will be coming out shortly and will be available on our website). The event is a great way to network, share information and provide educational feedback, latest developments in EQA and to say thank you for the ongoing support to all those involved in EQA.

This year sees the 40-year anniversary for UK NEQAS Parasitology (1986-2026) and with the annual event providing an opportunity for UK NEQAS Microbiology and Parasitology staff to meet participants, distributors and other stakeholders in-person, it is a perfect time to celebrate.

Epigenetics is a rapidly developing area of cellular biology, which is believed to be just as closely associated with the development of cancer and disease as the genetic mutation of DNA. In the future, cellular pathology will no doubt be more and more focused on the identification of each patients' personalised genetic and epigenetic status to combat cancer and disease. This focussed webinar looks at the discovery of epigenetics, and provide a simple, general understanding of its functionality and how it impacts cellular biology and genetics.

Time: 10:00 - 11:00am

Weqas is pleased to announce that its 2026 Two-Day POCT Conference will be held in London on Tuesday 8 and Wednesday 9 December 2026. The programme will feature EQA interpretation of POCT results, complemented by an interactive case studies workshop, and a series of invited external speakers will present on a range of current and emerging topics relevant to the POCT community. A full programme will be announced later in the year. Attendance for both conference days is free for NHS staff.

This webinar provides a basic introduction and understanding to the theory, principles and application and practical experience in muscle biopsies in diagnostic cellular pathology. This webinar takes place over the course of two sessions and is suitable for anyone who has a biomedical science background and wishes to gain an understanding of fresh muscle biopsies, and for those students and laboratory personnel completing the IBMS Specialist Portfolio in Cellular Pathology. This webinar includes a troubleshooting guide, from sampling and preparation, through to staining. 

Times: 10:00 - 12:00pm and 13:00 - 15:00pm 

This webinar takes place over the course of two sessions. Part one will explore the structure, function, and cells of the marrow, and discuss the clinical importance of the bone marrow trephine biopsy. Part two will explore fixation, decalcification, staining of the bone marrow trephine biopsy, and discuss potential challenges. This webinar is suitable for anyone who has a biomedical science background and wishes to gain an understanding of the theory and practice involved in current bone marrow trephines (BMT) techniques, and for those students & laboratory personnel completing the IBMS Specialist Portfolio in Cellular Pathology.

Times: 10:00 - 12:00pm and 13:00 - 15:00pm